Dermatologicals is set to record higher value growth, with 6% value growth predicted against 4% recorded in 2019. Demand for topical germicidals/antiseptics was boosted in Q1 and Q2 by the outbreak of COVID-19, with consumers stockpiling behaviour leading to a predicted double-digit increase in value growth for the products.
Antiparasitics/lice (head and body) treatments is expected to see a decline in value growth due to temporary COVID-19 restrictions. As schools and kindergartens were both closed for a period of time, beginning in March 2020, this saw a declining the spread of lice.
The top-ranked brands tend to drive sales in dermatologicals, as consumers are reluctant to try out new or lesser-known brands. The competitive landscape, therefore, often remains fixed, as Norwegians are usually reluctant to try out unrecognised products, uncertain of the quality of these.
Following an uplift in growth in 2020, due to frequent handwashing and sanitising, causing skin irritations, growth is set to reduce in 2021, though it will remain positive. The biggest influence of reduced growth will come from topical germicidals/antiseptics.
Pollution and global warming are set to continue driving growth for certain dermatologicals across the forecast period. Due to longer and warmer days, the number of patients suffering from sun-related allergies is expected to increase.
Eczema and dry skin are relatively common in Norway, and the cold and harsh winters are key issues that impact skin negatively. Therefore, sales of antipruritics are expected to remain positive over the forecast period, with the product driving value growth.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page